title: [Hepatitis C immunology].
abstract: This review summarizes what is currently known about the cellular and humoral immune responses to hepatitis C virus. The results of viral protein immunogenicity studies reported so far are analyzed, and points of controversy about the immunology and immunopathology of hepatitis C are discussed. A body of evidence supports the existence in hepatitis C virus-infected subjects of strong humoral and cellular immune responses. HCV Core, NS3 and NS4 proteins are the most immunogenic antigens for B cells and HLA class II-restricted CD4+ T cells. For its part, liver-infiltrating CD8+ CTL recognize epitopes within the Core, E1, E2/NS1 and NS2 proteins in a HLA class I restricted manner. CTL responses to HCV Core, NS3, NS4 and NS5 have been detected in peripheral blood of patients chronically infected with HCV. Although these B and T cell responses may contribute to clear the virus, in most cases they are unable to resolve chronic HCV infections. No protective B or T cell epitope has been found yet. It is becoming clearer that the immune response plays a fundamental role in the pathogenesis of liver disease in hepatitis C patients.
authors.affiliation: Instituto de Investigación Científica, Facultad de Medicina, Universidad Juárez del Estado de Durango, México. iicujed@gauss.logicnet.com.mx
authors.forename: C
authors.initials: C
authors.lastname: Alvarado Esquivel
authors.forename: G
authors.initials: G
authors.lastname: Leroux-Roels
mesh_terms: D016207:Cytokines / Q000096:biosynthesis; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000276:immunology*; D018937:Hepatitis C Antibodies / Q000096:biosynthesis; D006801:Humans; D013601:T-Lymphocytes / Q000276:immunology; D014761:Viral Hepatitis Vaccines
chemical_list: D016207:Cytokines; D018937:Hepatitis C Antibodies; D014761:Viral Hepatitis Vaccines